205 related articles for article (PubMed ID: 29477302)
21. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling.
Niedermaier T; Weigl K; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Jun; 32(6):481-493. PubMed ID: 28667446
[TBL] [Abstract][Full Text] [Related]
23. Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice.
Oluloro A; Petrik AF; Turner A; Kapka T; Rivelli J; Carney PA; Saha S; Coronado GD
J Community Health; 2016 Aug; 41(4):864-70. PubMed ID: 26874943
[TBL] [Abstract][Full Text] [Related]
24. Patient Non-adherence and Cancellations Are Higher for Screening Colonoscopy Compared with Surveillance Colonoscopy.
Greenspan M; Chehl N; Shawron K; Barnes L; Li H; Avery E; Sims S; Losurdo J; Mobarhan S; Melson J
Dig Dis Sci; 2015 Oct; 60(10):2930-6. PubMed ID: 25902746
[TBL] [Abstract][Full Text] [Related]
25. Patient-Initiated Colonoscopy Scheduling Effectively Increases Colorectal Cancer Screening Adherence.
Mankaney G; Rizk M; Sarvepalli S; Bongorno J; Garber A; Lopez R; McMichael J; Burke CA
Dig Dis Sci; 2019 Sep; 64(9):2497-2504. PubMed ID: 30877609
[TBL] [Abstract][Full Text] [Related]
26. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study.
Guo F; Chen C; Schöttker B; Holleczek B; Hoffmeister M; Brenner H
Int J Cancer; 2020 May; 146(9):2423-2432. PubMed ID: 31291471
[TBL] [Abstract][Full Text] [Related]
27. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
[TBL] [Abstract][Full Text] [Related]
28. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
[TBL] [Abstract][Full Text] [Related]
29. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
[TBL] [Abstract][Full Text] [Related]
30. The Need for an Integrated Patient Navigation Pathway to Improve Access to Colonoscopy After Positive Fecal Immunochemical Testing: A Safety-Net Hospital Experience.
Thamarasseril S; Bhuket T; Chan C; Liu B; Wong RJ
J Community Health; 2017 Jun; 42(3):551-557. PubMed ID: 27796633
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Performance of One-off Flexible Sigmoidoscopy with Fecal Immunochemical Testing in a Large Screening Population.
Niedermaier T; Weigl K; Hoffmeister M; Brenner H
Epidemiology; 2018 May; 29(3):397-406. PubMed ID: 29287053
[TBL] [Abstract][Full Text] [Related]
32. Factors Influencing Colorectal Cancer Screening Among Thais in the U.S.
Lee E; Natipagon-Shah B; Sangsanoi-Terkchareon S; Warda US; Lee SY
J Community Health; 2019 Apr; 44(2):230-237. PubMed ID: 30341745
[TBL] [Abstract][Full Text] [Related]
33. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
[TBL] [Abstract][Full Text] [Related]
34. [Screening for colorectal cancer in Italy, 2010 survey].
Zorzi M; Fedato C; Grazzini G; Sassoli de' Bianchi P; Naldoni C; Pendenza M; Sassatelli R; Senore C; Visioli CB; Zappa M
Epidemiol Prev; 2012; 36(6 Suppl 1):55-77. PubMed ID: 23293271
[TBL] [Abstract][Full Text] [Related]
35. Rolling-out Screening Volume Affecting Compliance Rate and Waiting Time of FIT-based Colonoscopy.
Jen HH; Hsu CY; Chen SL; Yen AM; Chiu SY; Fann JC; Lee YC; Wu MS; Hsu WF; Peng SM; Chen HH; Chiu HM
J Clin Gastroenterol; 2018 Oct; 52(9):821-827. PubMed ID: 29095416
[TBL] [Abstract][Full Text] [Related]
36. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
[TBL] [Abstract][Full Text] [Related]
37. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
[TBL] [Abstract][Full Text] [Related]
38. USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing.
Berger BM; Parton MA; Levin B
Am J Manag Care; 2016 Feb; 22(2):e77-81. PubMed ID: 26881323
[TBL] [Abstract][Full Text] [Related]
39. Barriers and Facilitators of Colorectal Cancer Screening in a Federally Qualified Health Center (FQHC).
Ylitalo KR; Camp BG; Umstattd Meyer MR; Barron LA; Benavidez G; Hess B; Laschober R; Griggs JO
J Am Board Fam Med; 2019; 32(2):180-190. PubMed ID: 30850454
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
